Market Cap: $107.52M
VI
Voyager Therapeutics, Inc.
VYGR
NASDAQ (NASDAQ Global Select)USD
Market Cap: $107.52M
Voyager Therapeutics positions itself as a growth option in the gene therapy sector, particularly in the treatment of neurological diseases. The company's recent performance reveals critical insights…
Voyager Therapeutics Advances in Gene Therapy Amid Strong Q4 Performance Voyager Therapeutics showcases robust growth in its Q4 earnings announcement, reflecting the company’s strong commitment to dev…
Voyager Therapeutics Advances Gene Therapy Pipeline Amid Strong Financial Position Voyager Therapeutics, a leading player in the biotech sector, showcases its robust financial health and commitment to…
Navigating the Complexities of Gene Therapy Development: A Challenge for UniQure UniQure encounters significant challenges with the U.S. Food and Drug Administration (FDA) regarding its gene therapy f…
Gene Therapy Controversy: UniQure's Huntington's Disease Treatment at a Crossroads UniQure finds itself under intense scrutiny from the U.S. Food and Drug Administration (FDA) regarding its novel gene…
FDA Scrutiny Intensifies Over UniQure's Huntington's Disease Gene Therapy In a recent development illuminating the challenges in gene therapy approvals, the U.S. Food and Drug Administration (FDA) rai…
Voyager Therapeutics Showcases Innovations in Gene Therapy at HC Wainwright Conference Voyager Therapeutics, a pioneering biotechnology company specializing in gene therapies for severe neurological d…
Voyager Therapeutics Showcases Gene Therapy Innovations at HC Wainwright Conference Voyager Therapeutics, Inc., a pioneering biotechnology firm focused on gene therapies for severe neurological diseas…
Voyager Therapeutics Showcases Gene Therapy Innovations at HC Wainwright Conference Voyager Therapeutics, a leading biotechnology firm specializing in gene therapies for severe neurological diseases,…